ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Expandable Nanocomposite Shape-Memory Hemostat for the Treatment of Noncompressible Hemorrhage.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Tunable Fabrication of 2D-Layered Magnesium Nanosilicates With Hemostatic Properties.Small science · 2026Article
- Adhesive and Hemostatic Hydrogel for the Management of Postpartum Hemorrhage.ACS applied materials & interfaces · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Noncompressible hemorrhage is a leading cause of death in both combat and lay settings, primarily due to the challenges in accessing and treating injuries deep within abdominal tissues where traditional compression-based methods are ineffective. Existing hemostatic materials fail to address the needs of large wound cavities, necessitating the development of advanced materials with rapid expansion and superior hemostatic properties. Here we report an expandable hemostat engineered from a nanocomposite-coated shape memory foam. This material exhibits rapid expansion, achieving a ~5X increase in volume within 3 min in vitro, and demonstrates notable shape recovery in vivo. The material's hemostatic efficacy is evident through a ~70% reduction in clotting time compared to untreated controls, primarily due to the ability to adhere platelets and red blood cells. Moreover, the composite material displays excellent hemocompatibility and cytocompatibility, with low hemolysis rates and high cellular viability. In vivo assessments further confirm its effectiveness, showing an accelerated clotting time (~80% reduction) and decreased blood loss (~50% decrease), alongside minimal inflammation and necrosis in histological analyses. Additionally, the composite demonstrates good biocompatibility following subcutaneous implantation, illustrating its efficacy in vivo. Overall, the synergistic effect of rapid expansion by shape memory foam, along with the excellent procoagulant ability of the nanocomposite makes this biocompatible, expandable hemostat a promising treatment for noncompressible hemorrhage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.